Lalu Muhammad Irham

13.3k total citations
74 papers, 275 citations indexed

About

Lalu Muhammad Irham is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Lalu Muhammad Irham has authored 74 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Epidemiology and 10 papers in Oncology. Recurrent topics in Lalu Muhammad Irham's work include Cancer Genomics and Diagnostics (4 papers), vaccines and immunoinformatics approaches (4 papers) and Asthma and respiratory diseases (4 papers). Lalu Muhammad Irham is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), vaccines and immunoinformatics approaches (4 papers) and Asthma and respiratory diseases (4 papers). Lalu Muhammad Irham collaborates with scholars based in Indonesia, Taiwan and United States. Lalu Muhammad Irham's co-authors include Wirawan Adikusuma, Wei‐Chiao Chang, Dyah Aryani Perwitasari, Shie‐Liang Hsieh, Marcus J. Calkins, Henry Sung-Ching Wong, Wan‐Chen Huang, Rockie Chong, Wei‐Pin Chang and Made Ary Sarasmita and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Lalu Muhammad Irham

48 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lalu Muhammad Irham Indonesia 9 96 69 37 35 31 74 275
Wirawan Adikusuma Indonesia 10 83 0.9× 65 0.9× 37 1.0× 34 1.0× 25 0.8× 64 296
Dong Xi China 9 72 0.8× 139 2.0× 46 1.2× 68 1.9× 44 1.4× 12 285
Rosalinda H. Arends United States 9 38 0.4× 136 2.0× 15 0.4× 32 0.9× 36 1.2× 11 262
Manoj Khokhar India 11 137 1.4× 50 0.7× 51 1.4× 57 1.6× 26 0.8× 36 379
Lloyd Tanner Sweden 11 144 1.5× 63 0.9× 44 1.2× 51 1.5× 30 1.0× 20 335
Xiaoyan Ding China 12 98 1.0× 165 2.4× 30 0.8× 41 1.2× 27 0.9× 33 459
Ahmed A. Abokor United States 8 115 1.2× 88 1.3× 45 1.2× 43 1.2× 44 1.4× 13 286
Hideaki Eto Japan 10 31 0.3× 40 0.6× 36 1.0× 30 0.9× 43 1.4× 19 385
Shweta Birla India 9 110 1.1× 94 1.4× 27 0.7× 27 0.8× 17 0.5× 22 294

Countries citing papers authored by Lalu Muhammad Irham

Since Specialization
Citations

This map shows the geographic impact of Lalu Muhammad Irham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lalu Muhammad Irham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lalu Muhammad Irham more than expected).

Fields of papers citing papers by Lalu Muhammad Irham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lalu Muhammad Irham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lalu Muhammad Irham. The network helps show where Lalu Muhammad Irham may publish in the future.

Co-authorship network of co-authors of Lalu Muhammad Irham

This figure shows the co-authorship network connecting the top 25 collaborators of Lalu Muhammad Irham. A scholar is included among the top collaborators of Lalu Muhammad Irham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lalu Muhammad Irham. Lalu Muhammad Irham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Irham, Lalu Muhammad, et al.. (2025). The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review. Basic & Clinical Pharmacology & Toxicology. 137(2). e70082–e70082.
2.
Irham, Lalu Muhammad, et al.. (2025). Pharmacogenomics for treatment response in patients with Stevens-Johnson syndrome: An updated review. Scripta Medica. 56(6). 601–609.
3.
Irham, Lalu Muhammad, et al.. (2024). Genetic-driven biomarkers for liver fibrosis through bioinformatic approach. SHILAP Revista de lepidopterología. 25(1).
4.
Süzen, H. Sinan, et al.. (2024). An overview on Sjögren’s syndrome and systemic lupus erythematosus’ genetics. Toxicology Research. 14(1). tfae194–tfae194. 1 indexed citations
5.
Adikusuma, Wirawan, et al.. (2024). Potential biomarker signatures in male infertility: integrative genomic analysis. SHILAP Revista de lepidopterología. 25(1). 1 indexed citations
6.
Irham, Lalu Muhammad, et al.. (2024). Promising candidate drug target genes for repurposing in cervical cancer: A bioinformatics-based approach. Narra J. 4(3). e938–e938. 1 indexed citations
7.
Irham, Lalu Muhammad, et al.. (2024). Harnessing genomic and bioinformatic data to broaden understanding of leukaemia across continents. SHILAP Revista de lepidopterología. 55(6). 717–725.
8.
Irham, Lalu Muhammad, et al.. (2024). Atherosclerosis research in the genomic era: global trends from 1983 to 2024. SHILAP Revista de lepidopterología. 30(4). 40–48.
9.
Irham, Lalu Muhammad, et al.. (2023). Publication trend of TMPRSS2 as SARS-CoV-2 receptor during the COVID-19 pandemic. SHILAP Revista de lepidopterología. 13(1). 58–58.
10.
Irham, Lalu Muhammad, et al.. (2023). DIABETES DISTRESS PADA PASIEN DIABETES MELLITUS TIPE 2 YANG MENGGUNAKAN INSULIN DI APOTEK X. Medical Sains Jurnal Ilmiah Kefarmasian. 8(2). 511–518.
11.
Irham, Lalu Muhammad, et al.. (2023). Adherence to iron supplementation among anemic pregnant women during 1964-2022: A bibliometric analysis. SHILAP Revista de lepidopterología. 9(1). 1–12. 2 indexed citations
12.
Adikusuma, Wirawan, et al.. (2023). Transcriptomics-driven drug repositioning for the treatment of diabetic foot ulcer. Scientific Reports. 13(1). 6 indexed citations
13.
Perwitasari, Dyah Aryani, et al.. (2023). Quality of Life of Cancer Patients during Chemotherapy in Indonesia: A Comparison of EORTC QLQ-C30 and EQ-5D-5L, Based on Patients’ Characteristics. International Journal of Clinical Practice. 2023. 1–9. 3 indexed citations
14.
Irham, Lalu Muhammad, et al.. (2023). A bioinformatic approach to identify pathogenic variants for Stevens-Johnson syndrome. Genomics & Informatics. 21(2). e26–e26. 2 indexed citations
15.
Adikusuma, Wirawan, et al.. (2023). Integrated genomic network analysis revealed potential of a druggable target for hemorrhoid treatment. Saudi Pharmaceutical Journal. 31(12). 101831–101831. 6 indexed citations
16.
Adikusuma, Wirawan, et al.. (2022). Identification of Druggable Genes for Asthma by Integrated Genomic Network Analysis. Biomedicines. 10(1). 113–113. 20 indexed citations
17.
Irham, Lalu Muhammad, et al.. (2022). Identification of Potential Treatments for Acute Lymphoblastic Leukemia through Integrated Genomic Network Analysis. Pharmaceuticals. 15(12). 1562–1562. 4 indexed citations
18.
Irham, Lalu Muhammad, Yu‐Shiuan Wang, Wirawan Adikusuma, et al.. (2020). Evaluation for the Genetic Association between Store-Operated Calcium Influx Pathway (STIM1 and ORAI1) and Human Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection. Biology. 9(11). 388–388. 15 indexed citations
19.
Perwitasari, Dyah Aryani, et al.. (2020). Genotype of Potassium Inwardly Rectifying Channel, Subfamily J, Member 11 (KCNJ 11) Gene and Glycaemia Control in Diabetic Patients: A Narrative Review. Systematic Reviews in Pharmacy. 11(9). 627–631. 1 indexed citations
20.
Irham, Lalu Muhammad, et al.. (2020). Integration of genetic variants and gene network for drug repurposing in colorectal cancer. Pharmacological Research. 161. 105203–105203. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026